{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:26:13Z","timestamp":1793726773706,"version":"4.6.1"},"reference-count":73,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CVP"],"published-print":{"date-parts":[[2020,1,27]]},"abstract":"<jats:sec><jats:title\/><jats:p>Diabetic foot ulcers (DFUs) are one of the major complications of diabetes, representing a leading cause of hospitalisation and non-traumatic lower limb amputations. Multidisciplinary management, patient education, glucose control, debridement, off-loading, infection control, and adequate perfusion are the mainstays of standard care. Despite all these, at least 30% of DFUs fail to heal within 20 weeks. Therefore, dermoepidermal skin substitutes (DSS) have been used as a new therapeutic adjunct for DFUs. This brief review outlines the recent advances in DSS for the treatment of DFUs. PubMed and Cochrane databases were systematically searched in May to July 2018 for systematic reviews published after 2013 and for randomised controlled trials (RCTs). A retrospective evaluation of 28 RCTs was performed. Rates of complete wound closure and time to healing were examined for 17 commonly available DSS. Healing rates after 12 weeks and time to complete closure in DFUs are heterogeneous among the 28 RCT. The best healing rates at 12 weeks were accomplished with dermal cellular substitutes (Epifix&amp;#174;, 100% and Amnioband&amp;#174;, 85%) and with dermal acellular substitutes (Allopatch&amp;#174;, 80% and Hyalograft&amp;#174;, 78.8%). Based on these studies, DSS used in conjunction with standard care appear to improve the healing rates of DFUs, as compared with standard care alone. Nonetheless, new studies with more homogeneous samples are needed to ascertain the role of ulcer size, duration, depth and\/or type in the efficacy of DSS. Moreover, future RCTs should include patients with severe comorbidities, in order to be more representative of clinical reality.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1570161117666190408170144","type":"journal-article","created":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T11:44:27Z","timestamp":1554810267000},"page":"182-192","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Advances in Dermoepidermal Skin Substitutes for Diabetic Foot Ulcers"],"prefix":"10.2174","volume":"18","author":[{"given":"Francisco Javier","family":"\u00c1lvaro-Afonso","sequence":"first","affiliation":[{"name":"Diabetic Foot Unit, University Podiatric Clinic, Edificio Facultad de Medicina, Complutense University of Madrid, Instituto de Investigacion Sanitaria del Hospital Cli\u0301nico San Carlos (IdISSC), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Garc\u00eda-\u00c1lvarez","sequence":"additional","affiliation":[{"name":"Diabetic Foot Unit, University Podiatric Clinic, Edificio Facultad de Medicina, Complutense University of Madrid, Instituto de Investigacion Sanitaria del Hospital Cli\u0301nico San Carlos (IdISSC), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"L\u00e1zaro-Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Diabetic Foot Unit, University Podiatric Clinic, Edificio Facultad de Medicina, Complutense University of Madrid, Instituto de Investigacion Sanitaria del Hospital Cli\u0301nico San Carlos (IdISSC), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despoina","family":"Kakagia","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Democritus University of Thrace, University Hospital of Alexandroupolis, Alexandroupolis, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Papanas","sequence":"additional","affiliation":[{"name":"Diabetes Centre-Diabetic Foot Clinic, Second Department of Internal Medicine, Democritus University of Thrace, University Hospital of Alexandroupolis, Alexandroupolis, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/S0140-6736(05)67698-2","volume":"366","author":"Boulton A.J.","year":"2005","unstructured":"Boulton A.J.; Vileikyte L.; Ragnarson-Tennvall G.; The global burden of diabetic foot disease. Lancet 2005,366,1719-1724","journal-title":"Lancet"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/1534734611400257","volume":"10","author":"Garcia-Morales E.","year":"2011","unstructured":"Garcia-Morales E.; Lazaro-Martinez J.L.; Martinez-Hernandez D.; Impact of diabetic foot related complications on the Health Related Quality of Life (HRQol) of patients: A regional study in Spain. Int J Low Extrem Wounds 2011,10,6-11","journal-title":"Int J Low Extrem Wounds"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1056\/NEJMra1615439","volume":"376","author":"Armstrong D.G.","year":"2017","unstructured":"Armstrong D.G.; Boulton A.J.M.; Bus S.A.; Diabetic foot ulcers and their recurrence. N Engl J Med 2017,376,2367-2375","journal-title":"N Engl J Med"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/jama.293.2.217","volume":"293","author":"Singh N.","year":"2005","unstructured":"Singh N.; Armstrong D.G.; Lipsky B.A.; Preventing foot ulcers in patients with diabetes. JAMA 2005,293,217-228","journal-title":"JAMA"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejvs.2013.03.024","volume":"46","author":"Fortington L.V.","year":"2013","unstructured":"Fortington L.V.; Geertzen J.H.; van Netten J.J.; Short and long term mortality rates after a lower limb amputation. Eur J Vasc Endovasc Surg 2013,46,124-131","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jamcollsurg.2004.05.270","volume":"199","author":"Sandnes D.K.","year":"2004","unstructured":"Sandnes D.K.; Sobel M.; Flum D.R.; Survival after lower-extremity amputation. J Am Coll Surg 2004,199,394-402","journal-title":"J Am Coll Surg"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1742-481X.2007.00392.x","volume":"4","author":"Armstrong D.G.","year":"2007","unstructured":"Armstrong D.G.; Wrobel J.; Robbins J.M.; Guest Editorial: Are diabetes-related wounds and amputations worse than cancer? Int Wound J 2007,4,286-287","journal-title":"Int Wound J"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.diabres.2018.05.004","volume":"141","author":"Lopez-Valverde M.E.","year":"2018","unstructured":"Lopez-Valverde M.E.; Aragon-Sanchez J.; Lopez-de-Andres A.; Perioperative and long-term all-cause mortality in patients with diabetes who underwent a lower extremity amputation. Diabetes Res Clin Pract 2018,141,175-180","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=9","volume":"1","author":"Fernando M.E.","year":"2016","unstructured":"Fernando M.E.; Seneviratne R.M.; Tan Y.M.; Intensive versus conventional glycaemic control for treating diabetic foot ulcers. Cochrane Database Syst Rev 2016,1","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"S192","DOI":"10.1002\/dmrr.855","volume":"24","author":"Bus S.A.","year":"2008","unstructured":"Bus S.A.; Valk G.D.; van Deursen R.W.; Specific guidelines on footwear and offloading. Diabetes Metab Res Rev 2008,24(Suppl. 1),S192-S193","journal-title":"Diabetes Metab Res Rev"},{"key":"ref=11","volume":"1","author":"Lewis J.","year":"2013","unstructured":"Lewis J.; Lipp A.; Pressure-relieving interventions for treating diabetic foot ulcers. Cochrane Database Syst Rev 2013,1","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=12","volume":"1","author":"Edwards J.","year":"2010","unstructured":"Edwards J.; Stapley S.; Debridement of diabetic foot ulcers. Cochrane Database Syst Rev 2010,1","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"158S","DOI":"10.1097\/PRS.0000000000002681","volume":"138","author":"Game F.L.","year":"2016","unstructured":"Game F.L.; Jeffcoate W.J.; Dressing and diabetic foot ulcers: A current review of the evidence. Plast Reconstr Surg 2016,138(3)(Suppl.),158S-164S","journal-title":"Plast Reconstr Surg"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1007\/s00125-012-2558-5","volume":"55","author":"Dumville J.C.","year":"2012","unstructured":"Dumville J.C.; Soares M.O.; O\u2019Meara S.; Systematic review and mixed treatment comparison: Dressings to heal diabetic foot ulcers. Diabetologia 2012,55,1902-1910","journal-title":"Diabetologia"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2147\/TCRM.S131193","volume":"13","author":"Liu S.","year":"2017","unstructured":"Liu S.; He C.Z.; Cai Y.T.; Evaluation of negative-pressure wound therapy for patients with diabetic foot ulcers: Systematic review and meta-analysis. Ther Clin Risk Manag 2017,13,533-544","journal-title":"Ther Clin Risk Manag"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"2088-94 e2","DOI":"10.1016\/j.clinthera.2017.08.014","volume":"39","author":"Zhao D","year":"2017","unstructured":"Zhao D; Luo S; Xu W; Efficacy and safety of hyperbaric oxygen therapy used in patients with diabetic foot: A meta-analysis of randomized clinical trials. Clin Ther 2017,39,2088-94 e2","journal-title":"Clin Ther"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"278","DOI":"10.12968\/jowc.2018.27.5.278","volume":"27","author":"Lazaro-Martinez J.L.","year":"2018","unstructured":"Lazaro-Martinez J.L.; Alvaro-Afonso F.J.; Garcia-Alvarez Y.; Ultrasound-assisted debridement of neuroischaemic diabetic foot ulcers, clinical and microbiological effects: A case series. J Wound Care 2018,27,278-286","journal-title":"J Wound Care"},{"key":"ref=18","volume":"8","author":"Cruciani M.","year":"2013","unstructured":"Cruciani M.; Lipsky B.A.; Mengoli C.; Granulocyte-colony stimulating factors as adjunctive therapy for diabetic foot infections. Cochrane Database Syst Rev 2013,8","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/wrr.12434","volume":"24","author":"Santema T.B.","year":"2016","unstructured":"Santema T.B.; Poyck P.P.; Ubbink D.T.; Systematic review and meta-analysis of skin substitutes in the treatment of diabetic foot ulcers: Highlights of a cochrane systematic review. Wound Repair Regen 2016,24,737-744","journal-title":"Wound Repair Regen"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1464-5491.2004.01375.x","volume":"22","author":"Margolis D.J.","year":"2005","unstructured":"Margolis D.J.; Allen-Taylor L.; Hoffstad O.; Healing diabetic neuropathic foot ulcers: Are we getting better? Diabet Med 2005,22,172-176","journal-title":"Diabet Med"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1524-475X.2006.00176.x","volume":"14","author":"Steed D.L.","year":"2006","unstructured":"Steed D.L.; Attinger C.; Colaizzi T.; Guidelines for the treatment of diabetic ulcers. Wound Repair Regen 2006,14,680-692","journal-title":"Wound Repair Regen"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/1203475416664037","volume":"21","author":"Nicholas M.N.","year":"2017","unstructured":"Nicholas M.N.; Yeung J.; Current status and future of skin substitutes for chronic wound healing. J Cutan Med Surg 2017,21,23-30","journal-title":"J Cutan Med Surg"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","volume":"62","author":"Liberati A.","year":"2009","unstructured":"Liberati A.; Altman D.G.; Tetzlaff J.; The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. J Clin Epidemiol 2009,62,e1-e34","journal-title":"J Clin Epidemiol"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.1996.03540080059030","volume":"276","author":"Begg C.","year":"1996","unstructured":"Begg C.; Cho M.; Eastwood S.; Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996,276,637-639","journal-title":"JAMA"},{"key":"ref=25","volume":"2","author":"Santema T.B.","year":"2016","unstructured":"Santema T.B.; Poyck P.P.; Ubbink D.T.; Skin grafting and tissue replacement for treating foot ulcers in people with diabetes. Cochrane Database Syst Rev 2016,2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1463-1326.2009.01164.x","volume":"12","author":"Teng Y.J.","year":"2010","unstructured":"Teng Y.J.; Li Y.P.; Wang J.W.; Bioengineered skin in diabetic foot ulcers. Diabetes Obes Metab 2010,12,307-315","journal-title":"Diabetes Obes Metab"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cpm.2013.09.010","volume":"31","author":"Cook E.A.","year":"2014","unstructured":"Cook E.A.; Cook J.J.; Badri H.; Bioengineered alternative tissues. Clin Podiatr Med Surg 2014,31,89-101","journal-title":"Clin Podiatr Med Surg"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2337\/diacare.24.1.84","volume":"24","author":"Oyibo S.O.","year":"2001","unstructured":"Oyibo S.O.; Jude E.B.; Tarawneh I.; A comparison of two diabetic foot ulcer classification systems: The Wagner and the University of Texas wound classification systems. Diabetes Care 2001,24,84-88","journal-title":"Diabetes Care"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/iwj.12242","volume":"11","author":"Zelen C.M.","year":"2014","unstructured":"Zelen C.M.; Serena T.E.; Snyder R.J.; A prospective, randomised comparative study of weekly versus biweekly application of dehydrated human amnion\/chorion membrane allograft in the management of diabetic foot ulcers. Int Wound J 2014,11,122-128","journal-title":"Int Wound J"},{"key":"ref=30","first-page":"26","volume":"60","author":"Sanders L.","year":"2014","unstructured":"Sanders L.; Landsman A.S.; Landsman A.; A prospective, multicenter, randomized, controlled clinical trial comparing a bioengineered skin substitute to a human skin allograft. Ostomy Wound Manage 2014,60,26-38","journal-title":"Ostomy Wound Manage"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2337\/diacare.19.4.350","volume":"19","author":"Gentzkow G.D.","year":"1996","unstructured":"Gentzkow G.D.; Iwasaki S.D.; Hershon K.S.; Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care 1996,19,350-354","journal-title":"Diabetes Care"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/1534734609331597","volume":"8","author":"Edmonds M.","year":"2009","unstructured":"Edmonds M.; European, Australian Apligraf Diabetic Foot Ulcer Study G. Apligraf in the treatment of neuropathic diabetic foot ulcers. Int J Low Extrem Wounds 2009,8,11-18","journal-title":"Int J Low Extrem Wounds"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/iwj.12566","volume":"13","author":"Zelen C.M.","year":"2016","unstructured":"Zelen C.M.; Serena T.E.; Gould L.; Treatment of chronic diabetic lower extremity ulcers with advanced therapies: A prospective, randomised, controlled, multi-centre comparative study examining clinical efficacy and cost. Int Wound J 2016,13,272-282","journal-title":"Int Wound J"},{"key":"ref=34","volume":"16","author":"Walters J.","year":"2016","unstructured":"Walters J.; Cazzell S.; Pham H.; Healing rates in a multicenter assessment of a sterile, room temperature, acellular dermal matrix versus conventional care wound management and an active comparator in the treatment of full-thickness diabetic foot ulcers. Eplasty 2016,16","journal-title":"Eplasty"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1742-481X.2009.00585.x","volume":"6","author":"Reyzelman A.","year":"2009","unstructured":"Reyzelman A.; Crews R.T.; Moore J.C.; Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: A prospective, randomised, multicentre study. Int Wound J 2009,6,196-208","journal-title":"Int Wound J"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/iwj.12954","volume":"15","author":"DiDomenico L.A.","year":"2018","unstructured":"DiDomenico L.A.; Orgill D.P.; Galiano R.D.; Use of an aseptically processed, dehydrated human amnion and chorion membrane improves likelihood and rate of healing in chronic diabetic foot ulcers: A prospective, randomised, multi-centre clinical trial in 80 patients. Int Wound J 2018,15,950-957","journal-title":"Int Wound J"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/iwj.12600","volume":"14","author":"Zelen C.M.","year":"2017","unstructured":"Zelen C.M.; Orgill D.P.; Serena T.; A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers. Int Wound J 2017,14,307-315","journal-title":"Int Wound J"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"521","DOI":"10.12968\/jowc.2014.23.11.521","volume":"23","author":"You H.J.","year":"2014","unstructured":"You H.J.; Han S.K.; Rhie J.W.; Randomised controlled clinical trial for autologous fibroblast-hyaluronic acid complex in treating diabetic foot ulcers. J Wound Care 2014,23,521-522","journal-title":"J Wound Care"},{"key":"ref=39","first-page":"158","volume":"27","author":"Smiell J.M.","year":"2015","unstructured":"Smiell J.M.; Treadwell T.; Hahn H.D.; Real-world experience with a decellularized dehydrated human amniotic membrane Allograft. Wounds 2015,27,158-169","journal-title":"Wounds"},{"key":"ref=40","first-page":"1531","volume":"136","author":"Margolis D.J.","year":"2000","unstructured":"Margolis D.J.; Kantor J.; Santanna J.; Risk factors for delayed healing of neuropathic diabetic foot ulcers: A pooled analysis. Arch Dermatol 2000,136,1531-1535","journal-title":"Arch Dermatol"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"S28-37","DOI":"10.12968\/jowc.2018.27.Sup7.S28","volume":"27","author":"Pacaccio DJ","year":"2018","unstructured":"Pacaccio DJ; Cazzell SM; Halperin GJ; Human placental membrane as a wound cover for chronic diabetic foot ulcers: A prospective, postmarket, CLOSURE study. J Wound Care 2018,27(Sup7),S28-37","journal-title":"J Wound Care"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00000658-198609000-00011","volume":"204","author":"Knighton D.R.","year":"1986","unstructured":"Knighton D.R.; Ciresi K.F.; Fiegel V.D.; Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF). Ann Surg 1986,204,322-330","journal-title":"Ann Surg"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00125-002-0868-8","volume":"45","author":"Lobmann R.","year":"2002","unstructured":"Lobmann R.; Ambrosch A.; Schultz G.; Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 2002,45,1011-1016","journal-title":"Diabetologia"},{"key":"ref=44","first-page":"483","author":"Shakespeare W.","year":"1988","unstructured":"Shakespeare W.; The merry wives of Windsor. The Complete Works of William Shakespeare 1988,483-508","journal-title":"The Complete Works of William Shakespeare"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/1534734614548167","volume":"13","author":"Papanas N.","year":"2014","unstructured":"Papanas N.; Mani R.; How to cope with the increasing burden of the diabetic foot: \u201cBetter three hours too soon than a minute too late. Int J Low Extrem Wounds 2014,13,171-172","journal-title":"Int J Low Extrem Wounds"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"498","DOI":"10.2174\/1570161114666160909162014","volume":"14","author":"Vas P.","year":"2016","unstructured":"Vas P.; Panagopoulos P.; Papanas N.; Editorial: \u201cAh, wherefore with infection should he live?\u201d: Microbial virulence factors in diabetic foot ulceration. Curr Vasc Pharmacol 2016,14,498-501","journal-title":"Curr Vasc Pharmacol"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/1534734618755582","volume":"17","author":"Vas P.R.J.","year":"2018","unstructured":"Vas P.R.J.; Edmonds M.; Kavarthapu V.; The Diabetic Foot Attack: \u201cTis Too Late to Retreat! Int J Low Extrem Wounds 2018,17,7-13","journal-title":"Int J Low Extrem Wounds"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0305-4179(99)00143-6","volume":"26","author":"Carsin H.","year":"2000","unstructured":"Carsin H.; Ainaud P.; Le Bever H.; Cultured epithelial autografts in extensive burn coverage of severely traumatized patients: a five year single-center experience with 30 patients. Burns 2000,26,379-387","journal-title":"Burns"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000321333","volume":"221","author":"Ortega-Zilic N.","year":"2010","unstructured":"Ortega-Zilic N.; Hunziker T.; Lauchli S.; EpiDex(R) Swiss field trial 2004-2008. Dermatology 2010,221,365-372","journal-title":"Dermatology"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1742-481X.2006.00209.x","volume":"3","author":"Brigido S.A.","year":"2006","unstructured":"Brigido S.A.; The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: A prospective 16-week pilot study. Int Wound J 2006,3,181-187","journal-title":"Int Wound J"},{"key":"ref=51","first-page":"228","volume":"23","author":"Caravaggi C.","year":"2011","unstructured":"Caravaggi C.; Grigoletto F.; Scuderi N.; Wound bed preparation with a dermal substitute (Hyalomatrix(R) PA) facilitates re-epithelialization and healing: Results of a multicenter, prospective, observational study on complex chronic ulcers (The FAST Study). Wounds 2011,23,228-235","journal-title":"Wounds"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.burns.2006.07.021","volume":"33","author":"Haslik W.","year":"2007","unstructured":"Haslik W.; Kamolz L.P.; Nathschlager G.; First experiences with the collagen-elastin matrix Matriderm as a dermal substitute in severe burn injuries of the hand. Burns 2007,33,364-368","journal-title":"Burns"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"476","DOI":"10.12968\/jowc.2012.21.10.476","volume":"21","author":"Lecheminant J.","year":"2012","unstructured":"Lecheminant J.; Field C.; Porcine urinary bladder matrix: A retrospective study and establishment of protocol. J Wound Care 2012,21,476","journal-title":"J Wound Care"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00129334-200506000-00012","volume":"18","author":"Niezgoda J.A.","year":"2005","unstructured":"Niezgoda J.A.; Van Gils C.C.; Frykberg R.G.; Randomized clinical trial comparing OASIS wound matrix to regranex gel for diabetic ulcers. Adv Skin Wound Care 2005,18,258-266","journal-title":"Adv Skin Wound Care"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.2337\/diacare.26.6.1701","volume":"26","author":"Marston W.A.","year":"2003","unstructured":"Marston W.A.; Hanft J.; Norwood P.; The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: Results of a prospective randomized trial. Diabetes Care 2003,26,1701-1705","journal-title":"Diabetes Care"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1525-1594.1997.tb00476.x","volume":"21","author":"Naughton G.","year":"1997","unstructured":"Naughton G.; Mansbridge J.; Gentzkow G.; A metabolically active human dermal replacement for the treatment of diabetic foot ulcers. Artif Organs 1997,21,1203-1210","journal-title":"Artif Organs"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/iwj.12097","volume":"10","author":"Zelen C.M.","year":"2013","unstructured":"Zelen C.M.; Serena T.E.; Denoziere G.; A prospective randomised comparative parallel study of amniotic membrane wound graft in the management of diabetic foot ulcers. Int Wound J 2013,10,502-507","journal-title":"Int Wound J"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/iwj.12395","volume":"12","author":"Zelen C.M.","year":"2015","unstructured":"Zelen C.M.; Gould L.; Serena T.E.; A prospective, randomised, controlled, multi-centre comparative effectiveness study of healing using dehydrated human amnion\/chorion membrane allograft, bioengineered skin substitute or standard of care for treatment of chronic lower extremity diabetic ulcers. Int Wound J 2015,12,724-732","journal-title":"Int Wound J"},{"key":"ref=59","first-page":"70","volume":"28","author":"Snyder R.J.","year":"2016","unstructured":"Snyder R.J.; Shimozaki K.; Tallis A.; A prospective, randomized, multicenter, controlled evaluation of the use of dehydrated amniotic membrane allograft compared to standard of care for the closure of chronic diabetic foot ulcer. Wounds 2016,28,70-77","journal-title":"Wounds"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/iwj.12329","volume":"11","author":"Lavery L.A.","year":"2014","unstructured":"Lavery L.A.; Fulmer J.; Shebetka K.A.; The efficacy and safety of Grafix ((R)) for the treatment of chronic diabetic foot ulcers: Results of a multi-centre, controlled, randomised, blinded, clinical trial. Int Wound J 2014,11,554-560","journal-title":"Int Wound J"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/iwj.12649","volume":"14","author":"Frykberg R.G.","year":"2017","unstructured":"Frykberg R.G.; Gibbons G.W.; Walters J.L.; A prospective, multicentre, open-label, single-arm clinical trial for treatment of chronic complex diabetic foot wounds with exposed tendon and\/or bone: positive clinical outcomes of viable cryopreserved human placental membrane. Int Wound J 2017,14,569-577","journal-title":"Int Wound J"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00000658-198110000-00005","volume":"194","author":"Burke J.F.","year":"1981","unstructured":"Burke J.F.; Yannas I.V.; Quinby W.C.; Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann Surg 1981,194,413-428","journal-title":"Ann Surg"},{"key":"ref=63","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/wrr.12357","volume":"23","author":"Driver V.R.","year":"2015","unstructured":"Driver V.R.; Lavery L.A.; Reyzelman A.M.; A clinical trial of Integra Template for diabetic foot ulcer treatment. Wound Repair Regen 2015,23,891-900","journal-title":"Wound Repair Regen"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1046\/j.1524-475X.1999.00201.x","volume":"7","author":"Falanga V.","year":"1999","unstructured":"Falanga V.; Sabolinski M.; A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen 1999,7,201-207","journal-title":"Wound Repair Regen"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.burns.2005.04.029","volume":"31","author":"Cassidy C.","year":"2005","unstructured":"Cassidy C.; St Peter S.D.; Lacey S.; Biobrane versus duoderm for the treatment of intermediate thickness burns in children: A prospective, randomized trial. Burns 2005,31,890-893","journal-title":"Burns"},{"key":"ref=66","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.2337\/diacare.26.10.2853","volume":"26","author":"Caravaggi C.","year":"2003","unstructured":"Caravaggi C.; De Giglio R.; Pritelli C.; HYAFF 11-based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: A prospective, multicenter, controlled, randomized clinical trial. Diabetes Care 2003,26,2853-2859","journal-title":"Diabetes Care"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2337\/diacare.24.2.290","volume":"24","author":"Veves A.","year":"2001","unstructured":"Veves A.; Falanga V.; Armstrong D.G.; Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: A prospective randomized multicenter clinical trial. Diabetes Care 2001,24,290-295","journal-title":"Diabetes Care"},{"key":"ref=68","first-page":"230","volume":"15","author":"Lipkin S.","year":"2003","unstructured":"Lipkin S.; Chaikof E.; Isseroff Z.; Effectiveness of bilayered cellular matrix in healing of neuropathic diabetic foot ulcers: Results of a multicenter pilot trial. Wounds 2003,15,230-236","journal-title":"Wounds"},{"key":"ref=69","first-page":"111","volume":"20","author":"Landsman A.","year":"2008","unstructured":"Landsman A.; Roukis T.S.; DeFronzo D.J.; Living cells or collagen matrix: Which is more beneficial in the treatment of diabetic foot ulcers? Wounds 2008,20,111-116","journal-title":"Wounds"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/1534734611409371","volume":"10","author":"Uccioli L.","year":"2011","unstructured":"Uccioli L.; Giurato L.; Ruotolo V.; Two-step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: Results of a multicenter, randomized controlled clinical trial with long-term follow-up. Int J Low Extrem Wounds 2011,10,80-85","journal-title":"Int J Low Extrem Wounds"},{"key":"ref=71","first-page":"184","volume":"23","author":"DiDomenico L.","year":"2011","unstructured":"DiDomenico L.; Landsman A.R.; Emch K.J.; A prospective comparison of diabetic foot ulcers treated with either a cryopreserved skin allograft or a bioengineered skin substitute. Wounds 2011,23,184-189","journal-title":"Wounds"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1524-475X.2012.00809.x","volume":"20","author":"You H.J.","year":"2012","unstructured":"You H.J.; Han S.K.; Lee J.W.; Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes: A pilot study. Wound Repair Regen 2012,20,491-499","journal-title":"Wound Repair Regen"},{"key":"ref=73","doi-asserted-by":"crossref","DOI":"10.1097\/GOX.0000000000001095","volume":"4","author":"DiDomenico L.A.","year":"2016","unstructured":"DiDomenico L.A.; Orgill D.P.; Galiano R.D.; Aseptically processed placental membrane improves healing of diabetic foot ulcerations: Prospective, randomized clinical trial. Plast Reconstr Surg Glob Open 2016,4","journal-title":"Plast Reconstr Surg Glob Open"}],"container-title":["Current Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/171455","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T19:21:58Z","timestamp":1721157718000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/171455\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,27]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,1,27]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570161117666190408170144","relation":{},"ISSN":["1570-1611"],"issn-type":[{"value":"1570-1611","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1,27]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-08-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}